Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selectio... Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%. Mehr anzeigen
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare technology company, today announced a unique...
COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. (Nasdaq: GH) that will allow...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a collaboration with Boehringer Ingelheim to pursue the regulatory approval and commercialization of the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.9 | -2.76923076923 | 32.5 | 32.745 | 30.71 | 1407607 | 31.37090024 | CS |
| 4 | -3.49 | -9.94585351952 | 35.09 | 38.53 | 30.71 | 1395892 | 34.71145325 | CS |
| 12 | 9.6 | 43.6363636364 | 22 | 38.53 | 20.14 | 1733350 | 28.32692464 | CS |
| 26 | 2.12 | 7.19131614654 | 29.48 | 38.53 | 20.14 | 1967443 | 28.34796991 | CS |
| 52 | 2.95 | 10.2966841187 | 28.65 | 38.53 | 15.81 | 1984613 | 25.43638981 | CS |
| 156 | -66.4 | -67.7551020408 | 98 | 102.85 | 15.81 | 1692503 | 33.3321832 | CS |
| 260 | -51.09 | -61.784980046 | 82.69 | 181.07 | 15.81 | 1415405 | 54.71627344 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
